All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @sarahhubes on TikTok · 150s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @sarahhubes's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00If I was brand new to starting a GLP one here are literally three things I would not do learn from my mistakes and do not do them
  2. 0:09number one eat too
  3. 0:11little I
  4. 0:13like
  5. 0:14Ralph's a handful of times in my first 12 months that I was on a
  6. 0:20GLP one because I didn't eat enough. I wasn't hungry and I also wasn't like
  7. 0:26Forcing myself to eat and I would eat literally like
  8. 0:32nuts or almonds or a hard gold egg or a piece of string cheese that is not enough
  9. 0:37Food so it's not enough nutrition and it's not enough protein
  10. 0:41so instead of eating like yogurt or
  11. 0:43Like protein granola. I would eat a little bit of yogurt put the protein granola on it and add in some fruit and then you're you know
  12. 0:51you're eating a dish of
  13. 0:54Yogurt that has like 30 grams of protein and you're more likely to not get nauseous
  14. 1:00number two is I didn't tell anyone when I first started and I really wish I should have because it just
  15. 1:07There's a lot of shame and a lot of stigma around these drugs and being over 40 on a GLP one
  16. 1:12I was just like it's nobody's business. I literally told no one no one and
  17. 1:17It was it was internally it was a struggle and I wouldn't recommend that to anybody else
  18. 1:22But to each their own if you don't want people to say things to you don't tell anybody either
  19. 1:27Three is not drinking up water. This is
  20. 1:30Obvious I used to be a big big big water drinker. I would carry around huge
  21. 1:36bottles of water everywhere I went like for the last
  22. 1:4025 years probably taking a GLP one makes you literally not feel like drinking water. It makes you
  23. 1:47not want to drink alcohol. It makes you not want to eat it makes you look now what it is that you used to do so
  24. 1:54It came from me and make sure you stay hydrated because
  25. 1:58Dehydration on a GLP one is
  26. 2:01No, but I know you don't have to go get an IV because you're dehydrated, right?
  27. 2:05I mean enough water keeps all of the things moving. I had a lot of like constipation on
  28. 2:11S when I was first taking it and it had a lot to do with the amount of water that I was drinking or not drinking
  29. 2:18so
  30. 2:19Those are the things this is never medical advice
  31. 2:21This is just my journey that I'm sharing
  32. 2:23I lost 50 pounds over the last 18 months on a GLP one and I'm an old book
  33. 2:28So let me know if you have questions

GLP-1 mistakes on TikTok: What the science actually says

SARAH THE XENNIAL

TikTok creator

2.2K viewsWatch on TikTok

Quick answer

GLP-1 receptor agonists suppress appetite via central hypothalamic pathways and slow gastric emptying, which can lead to inadvertent severe caloric and protein restriction if patients do not actively manage intake. Constipation affects roughly 24 percent of semaglutide users in phase 3 trial data and is worsened by reduced fluid consumption, a common behavioral consequence of generalized appetite and interest suppression. Preserving lean body mass during GLP-1-assisted weight loss requires deliberate protein targeting, typically 1.2 to 1.6 grams per kilogram of body weight per day according to Obesity Medicine Association guidance.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 10 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For GLP-1 mistakes on TikTok: What the science actually says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

GLP-1 mistakes on TikTok: What the science actually says should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "GLP-1 mistakes on TikTok: What the science actually says" from SARAH THE XENNIAL. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists suppress appetite via central hypothalamic pathways and slow gastric emptying, which can lead to inadvertent severe caloric and protein restriction if patients do not actively manage intake.

The reason this review is not generic is the source wording and the canonical claim label "glp1 learn from my mistakes if you re on a glp1 did you do any of." In this clip, the useful excerpt is: "If I was brand new to starting a GLP one here are literally three things I would not do learn from my mistakes and do not do them number one eat too little I like Ralph's a handful of times in my first 12 months that I was on a GLP one..." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Constipation affects roughly 24 percent of semaglutide users based on STEP 1 trial data, and reduced fluid intake worsens it by compounding slowed gastric motility.
People who land here are usually comparing the GLP-1 social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

GLP-1 receptor agonists suppress appetite via central hypothalamic pathways and slow gastric emptying, which can lead to inadvertent severe caloric and protein restriction if patients do not actively manage intake.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GLP-1 receptor agonists suppress appetite via central hypothalamic pathways and slow gastric emptying, which can lead to inadvertent severe caloric and protein restriction if patients do not actively manage intake. Constipation affects roughly 24 percent of semaglutide users in phase 3 trial data and is worsened by reduced fluid consumption, a common behavioral consequence of generalized appetite and interest suppression. Preserving lean body mass during GLP-1-assisted weight loss requires deliberate protein targeting, typically 1.2 to 1.6 grams per kilogram of body weight per day according to Obesity Medicine Association guidance.
  • Inadequate protein intake during GLP-1-assisted weight loss accelerates muscle loss: the Obesity Medicine Association recommends 1.2 to 1.6 grams of protein per kilogram of body weight daily, not occasional snacking.
  • Constipation affects roughly 24 percent of semaglutide users based on STEP 1 trial data, and reduced fluid intake worsens it by compounding slowed gastric motility.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Inadequate protein intake during GLP-1-assisted weight loss accelerates muscle loss: the Obesity Medicine Association recommends 1.2 to 1.6 grams of protein per kilogram of body weight daily, not occasional snacking.
  • Constipation affects roughly 24 percent of semaglutide users based on STEP 1 trial data, and reduced fluid intake worsens it by compounding slowed gastric motility.
  • GLP-1 medications do not pharmacologically suppress thirst the way they suppress hunger. Reduced water intake is a behavioral side effect of generalized appetite blunting, not a direct drug mechanism.
  • A single 30-gram protein meal is a useful starting point but does not meet most users' daily protein needs during active weight loss. Total daily intake must be tracked.
  • Weight stigma around GLP-1 use is documented in the research: Davies et al. (2022, Diabetes Care) found it was a barrier to both adherence and emotional wellbeing, supporting Sarah's account of internal struggle.
  • Rapid weight loss on GLP-1s without adequate nutrition and protein targets disproportionately reduces lean body mass, which has downstream effects on metabolism and long-term weight maintenance.
  • Nausea is best managed with smaller, nutrient-dense meals rather than skipping eating altogether. Avoiding food to manage nausea creates a cycle that worsens nutritional deficiency.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @sarahhubes actually say?

Sarah shared three personal mistakes from her first year on a GLP-1: eating too little ("nuts or almonds or a hard boiled egg" as a full day's intake), telling nobody she was on the medication due to stigma, and not drinking enough water. She connects dehydration directly to constipation and says she lost 50 pounds over 18 months. She's clear this is personal experience, not medical advice.

The framing is honest and self-deprecating. She's not selling anything or making dramatic health claims. That context matters when reading this fact-check, because her three points are largely practical and rooted in real physiological effects of GLP-1 medications, not wellness mythology.

Does the science back this up?

Yes, more than you might expect from a TikTok video. GLP-1 receptor agonists genuinely suppress appetite through central and peripheral mechanisms, and that suppression can cause people to undereat to the point of nutritional deficiency. The protein point she makes is particularly well-supported.

Research published by Wilding et al. (2021, NEJM) in the STEP 1 semaglutide trial noted that participants lost significant lean mass alongside fat mass, a problem directly linked to inadequate protein intake. More recently, Biggs et al. (2023, Obesity) found that patients on GLP-1 agonists who did not meet protein targets lost disproportionately more muscle. The dehydration-constipation link is also real. GLP-1 medications slow gastric motility, and reduced fluid intake compounds that effect. A review by Ard et al. (2021, Current Obesity Reports) identified constipation and dehydration as among the most underreported adverse effects. Her water advice is not glamorous, but it's grounded.

What did they get wrong (or right)?

She got the physiology mostly right. Where the video gets imprecise is the protein number she tosses out. Saying "30 grams of protein" in one yogurt bowl is fine as an example, but the implication that this solves the problem undersells how much protein GLP-1 users actually need across a full day.

Clinical guidance from groups like the Obesity Medicine Association generally recommends 1.2 to 1.6 grams of protein per kilogram of body weight for people actively losing weight on these medications, especially to preserve lean mass. A single 30-gram bowl doesn't get most people there. She also says GLP-1 medications make you "not want to drink water" as if it's a direct pharmacological effect. There's no strong evidence that GLP-1s specifically blunt thirst the way they blunt hunger. The more likely explanation is that general appetite and sensory interest in food and drink both decrease, and water gets caught in that behavioral shift. A small but meaningful distinction.

What should you actually know?

If you're on a GLP-1 and eating sporadically because you're just not hungry, that's not a win. It's a problem. Inadequate intake, particularly of protein, accelerates muscle loss during rapid weight reduction. That muscle loss has downstream consequences for metabolism, bone density, and long-term weight maintenance. The "I wasn't hungry so I didn't eat" pattern is one of the most common clinical errors providers see in GLP-1 patients.

Constipation is reported in roughly 24 percent of semaglutide users in clinical trials, according to the STEP trial data. Fluid intake, fiber, and movement all matter. If constipation is severe or persistent, that's a conversation for your prescriber, not just a water bottle problem. On the stigma point: her experience of internal struggle from not telling anyone is consistent with what qualitative research shows about weight stigma and medication shame. Davies et al. (2022, Diabetes Care) found that stigma around GLP-1 use was a barrier to adherence. Whether you tell people is your call, but the emotional weight of secrecy is real.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

SARAH THE XENNIAL · TikTok creator

2.2K views on this video

Learn from my mistakes. If you’re on a GLP1, did you do any of these? #gIp1 #wellnessjourney #glp1forweightloss #glp1tips #glp1maintenance #healthjourney #wellnessthatworks #glp1community #glp1sideeffects #perimenopause #perimenopausesupport #perimenopausehealth

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about inadequate protein intake during glp-1-assisted weight loss accelerates muscle loss:?

Inadequate protein intake during GLP-1-assisted weight loss accelerates muscle loss: the Obesity Medicine Association recommends 1.2 to 1.6 grams of protein per kilogram of body weight daily, not occasional snacking.

What does the video say about constipation affects roughly 24 percent of semaglutide users based on?

Constipation affects roughly 24 percent of semaglutide users based on STEP 1 trial data, and reduced fluid intake worsens it by compounding slowed gastric motility.

What does the video say about glp-1 medications do not pharmacologically suppress thirst the way they?

GLP-1 medications do not pharmacologically suppress thirst the way they suppress hunger. Reduced water intake is a behavioral side effect of generalized appetite blunting, not a direct drug mechanism.

What does the video say about a single 30-gram protein meal?

A single 30-gram protein meal is a useful starting point but does not meet most users' daily protein needs during active weight loss. Total daily intake must be tracked.

What does the video say about weight stigma around glp-1 use?

Weight stigma around GLP-1 use is documented in the research: Davies et al. (2022, Diabetes Care) found it was a barrier to both adherence and emotional wellbeing, supporting Sarah's account of internal struggle.

What does the video say about rapid weight loss on glp-1s without adequate nutrition?

Rapid weight loss on GLP-1s without adequate nutrition and protein targets disproportionately reduces lean body mass, which has downstream effects on metabolism and long-term weight maintenance.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by SARAH THE XENNIAL, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.